LADENBURG THALMANN FINANCIAL SERVICES INC. - CATABASIS PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CATABASIS PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$2,000
-33.3%
126
-77.5%
0.00%
Q3 2019$3,0005600.00%
Other shareholders
CATABASIS PHARMACEUTICALS IN shareholders Q2 2024
NameSharesValueWeighting ↓
SV Health Investors, LLC 285,765$1,837,0001.27%
Samsara BioCapital, LLC 300,000$1,929,0000.62%
Worth Venture Partners, LLC 137,425$883,0000.43%
Parkman Healthcare Partners LLC 155,473$1,000,0000.28%
Alyeska Investment Group, L.P. 1,125,000$7,234,0000.11%
Ovata Capital Management Ltd 30,000$193,0000.06%
FEDERATED HERMES, INC. 3,047,800$19,597,0000.05%
Curi RMB Capital, LLC 70,228$452,0000.02%
OPPENHEIMER & CO INC 107,461$691,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 90,300$581,0000.01%
View complete list of CATABASIS PHARMACEUTICALS IN shareholders